Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)

Clinical trial NCT06242691 · COMPLETED

Trial details

NCT number: NCT06242691
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-02-28
Primary completion: 2025-06-17
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.